Apr 14
Anthropic’s Long-Term Benefit Trust appoints Vas Narasimhan to Board of Directors
★★★★★
significance 2/5
Anthropic's Long-Term Benefit Trust has appointed Vas Narasimhan, CEO of Novartis, to its Board of Directors. The appointment aims to leverage Narasimhan's experience in highly regulated industries to help align Anthropic's AI development with its public benefit mission.
Why it matters
Bridging the gap between high-stakes biotechnology regulation and AI safety-driven governance signals a shift toward more rigorous, industry-specific oversight.
Entities mentioned
AnthropicTags
#anthropic #board appointment #governance #healthcare #ai safetyRelated coverage
- The News InternationalGoogle’s new Pentagon deal: A turning point for AI safety - The News International
- AnthropicAnthropic Sydney office
- 404 MediaUniversity Professors Disturbed to Find Their Lectures Chopped Up and Turned Into AI Slop
- The Verge AICanonical lays out a plan for AI in Ubuntu Linux
- Ars Technica AIOpenAI ends its exclusive partnership with Microsoft